A transdermal delivery system comprising a composition comprising a physiologicallyactive agent and a penetration enhancer wherein the penetration enhancer comprisesa combination of (i) an ester of salicylic acid, preferably selected from theC to C aliphatic ester of salicylic acid and (ii) polyethyleneglycol (PEG) of average molecular weight no more than 300.